SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Spherix Incorporated on October 18, 2010. The registrant is incorporated in Delaware with principal executive offices in Bethesda, Maryland. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding an upcoming event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely discloses a scheduled corporate presentation.
Guidance, Outlook, and Management Commentary
Upcoming Presentation: On November 3, 2010, Dr. Robert A. Lodder (President) and Ms. Leisa Dennehy (Commercial and Corporate Development Advisor) will deliver a company presentation at the Windhover's Therapeutic Area Partnerships Conference in Boston, MA.
Availability: The presentation is available on the Company's website (www.spherix.com) and is attached as Exhibit 99.1, incorporated by reference into this filing.
Key Facts for Investor Verification
- Verify the content of the "Spherix Incorporated Overview Presentation" attached as Exhibit 99.1 for any forward-looking statements or strategic updates.
- Confirm the date and location of the upcoming investor presentation (November 3, 2010, Boston, MA).
- Note that this filing contains no financial data; refer to the most recent 10-K or 10-Q for financial performance.